Showing 20 of 81 recruiting trials for “squamous-cell-carcinoma-of-head-and-neck”
The Efficacy and Safety of Neoadjuvant Low-dose Radiotherapy Combined With Chemoimmunotherapy in Locally Advanced HNSCC
RecruitingNCT05192655 ↗
Artificial Intelligence in Functional Imaging for Individualized Treatment of Head and Neck Squamous Cell Carcinoma Patients
RecruitingNCT05030597 ↗
Exploring the Application Value of PET Molecular Imaging Targeting FAP in Oral Squamous Cell Carcinoma
A Study of Toripalimab as Consolidation Therapy After Postoperative Chemoradiotherapy in HNSCC
Dose De-escalation and Sentinel LN Mapping Driven Radiotherapy of Contralateral Neck in Ipsilateral Node Positive HNSCC
👨⚕️ Jean-François Daisne, Prof. Dr., Universitaire Ziekenhuizen KU Leuven📍 10 sites📅 Started Jun 2021View details ↗
RecruitingNCT04892849 ↗
Clinical Benefit and Biomarker Analysis of Combination of PD-1/PD-L1 Immune Checkpoint Inhibitors and Radiotherapy
👨⚕️ Markus Hecht, PD Dr., Universitätsklinikum Erlangen, Department of Radiation Oncology📍 1 site📅 Started Apr 2021View details ↗
Study of Pembrolizumab Combined with Chemotherapy in the First Line Therapy for R/M HNSCC in China
👨⚕️ Yuankai Shi, MD, Cancer Institute/Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College📍 1 site📅 Started Apr 2021View details ↗
Neoadjuvant Camrelizumab in Combination With Cisplatin and Nab-paclitaxel in Resectable HNSCC
Induction and Maintenance Treatment With PARP Inhibitor and Immunotherapy in HPV-negative HNSCC
A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1
Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors
RecruitingNCT04567056 ↗
Specific Methylation Profiles in HNSCC
👨⚕️ Michael Gaihede, Professor, Department of Otolaryngology - Head and Neck Surgery, Aalborg University Hospital📍 1 site📅 Started Sep 2020View details ↗
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
Preservation of Swallowing in Respected Oral Cavity Squamous Cell Carcinoma: Examining Radiation Volume Effects (PRESERVE): A Randomized Trial
🏥 London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's📍 8 sites📅 Started Sep 2019View details ↗
RecruitingNCT04428515 ↗
Pilot Study to Evaluate Photoacoustic Imaging in Head and Neck Cancer
👨⚕️ Gregory J Czarnota, PhD, MD, Sunnybrook Health Sciences Centre📍 1 site📅 Started Apr 2019View details ↗
Study of NEO-201 in Solid Tumors Expansion Cohorts
👨⚕️ Kevin Conlon, MD, National Cancer Institute - Women's Malignancy Branch📍 2 sites📅 Started Jan 2019View details ↗
Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Oropharyngeal Cancer.
👨⚕️ Nader Sadeghi, MD, McGill University Health Centre/Research Institute of the McGill University Health Centre📍 1 site📅 Started Aug 2018View details ↗
Adjuvant Immunotherapy After Salvage Surgery in Head and Neck Squamous Cell Carcinoma
👨⚕️ Alix MARHIC, MD, Gustave Roussy, Cancer Campus, Grand Paris📍 1 site📅 Started Feb 2018View details ↗
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →